CY1115564T1 - METHODS OF HEALTH LOSS TREATMENT TREATMENT - Google Patents

METHODS OF HEALTH LOSS TREATMENT TREATMENT

Info

Publication number
CY1115564T1
CY1115564T1 CY20141100744T CY141100744T CY1115564T1 CY 1115564 T1 CY1115564 T1 CY 1115564T1 CY 20141100744 T CY20141100744 T CY 20141100744T CY 141100744 T CY141100744 T CY 141100744T CY 1115564 T1 CY1115564 T1 CY 1115564T1
Authority
CY
Cyprus
Prior art keywords
glutathione
treatment
hearing loss
methods
compositions comprise
Prior art date
Application number
CY20141100744T
Other languages
Greek (el)
Inventor
Jonathan Kil
Eric D Lynch
Original Assignee
Sound Pharmaceuticals Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03701231.7A external-priority patent/EP1471902B1/en
Application filed by Sound Pharmaceuticals Incorporated filed Critical Sound Pharmaceuticals Incorporated
Publication of CY1115564T1 publication Critical patent/CY1115564T1/en

Links

Abstract

Σε μία εκδοχή, η παρούσα εφεύρεση παρέχει ωτοπροστατευτικές συνθέσεις χρήσιμες στη βελτίωση της απώλειας ακοής. Σε κάποιες εφαρμογές, οι ωτοπροστατευτικές συνθέσεις περιλαμβάνουν τουλάχιστον ένα μιμητικό υπεροξειδάσης της γλουταθειόνης. Σε κάποιες εφαρμογές, οι ωτοπροστατευτικές συνθέσεις περιλαμβάνουν τουλάχιστον ένα μιμητικό υπεροξειδάσης της γλουταθειόνης και τουλάχιστον ένα ωτοπροστατευτικό που επιλέγεται από την ομάδα που περιλαμβάνει αναστολέα οξειδάσης της ξανθίνης και γλουταθειόνη ή πρόδρομο γλουταθειόνης. Σε κάποιες εφαρμογές, οι ωτοπροστατευτικές συνθέσεις περιλαμβάνουν τουλάχιστον ένα μιμητικό υπεροξειδάσης της γλουταθειόνης, τουλάχιστον έναν αναστολέα οξειδάσης της ξανθίνης, τουλάχιστον μία γλουταθειόνη ή έναν πρόδρομο γλουταθειόνης. Σε άλλη εκδοχή, η παρούσα εφεύρεση παρέχει μεθόδους βελτίωσης της απώλειας ακοής με χορήγηση σε ασθενή ποσότητας ωτοπροστατευτικής σύνθεσης, που είναι αποτελεσματική για τη βελτίωση της απώλειας ακοής.In one embodiment, the present invention provides ear protective compositions useful in improving hearing loss. In some applications, the protective compositions comprise at least one glutathione peroxidase mimetic. In some embodiments, the otoprotective compositions comprise at least one glutathione peroxidase mimetic and at least one otoprotective agent selected from the group comprising xanthine oxidase inhibitor and glutathione or glutathione precursor. In some embodiments, the protective compositions comprise at least one glutathione peroxidase mimetic, at least one xanthine oxidase inhibitor, at least one glutathione or a glutathione precursor. In another embodiment, the present invention provides methods of improving hearing loss by administering to a patient an amount of self-protective composition, which is effective in improving hearing loss.

CY20141100744T 2002-01-04 2014-09-15 METHODS OF HEALTH LOSS TREATMENT TREATMENT CY1115564T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34581302A 2002-01-04 2002-01-04
EP03701231.7A EP1471902B1 (en) 2002-01-04 2003-01-03 Compositions for use in methods for treating hearing loss

Publications (1)

Publication Number Publication Date
CY1115564T1 true CY1115564T1 (en) 2017-01-04

Family

ID=58461559

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100744T CY1115564T1 (en) 2002-01-04 2014-09-15 METHODS OF HEALTH LOSS TREATMENT TREATMENT

Country Status (1)

Country Link
CY (1) CY1115564T1 (en)

Similar Documents

Publication Publication Date Title
CY1119601T1 (en) PROTECTION PROMOTIONS
CY1117217T1 (en) COMPOSITION AND ANTI-VISUAL ACTIVITY OF SUBSTITUTED AZAIDOLOOXOXIC PRODUCERS OF Piperazine
CY1116992T1 (en) METHOD OF TREATMENT OF STRENGTHENING ILL-17 ACTIVITY
DE60312017D1 (en) SULPHONE DERIVATIVES FOR INHIBITING GAMMA SECRETASE
CY1111613T1 (en) METHODS FOR TREATMENT OF HIV INFECTION
CY1116784T1 (en) Antimicrobial compounds and methods for their use
CY1115745T1 (en) COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF OXALIC DISEASES
HUP0101594A2 (en) Use of parathormone for increasing bone toughness and stiffness and reducing fractures
DE50213462D1 (en) COATING OF STENTS TO PREVENT RESTENOSIS
CY1111246T1 (en) PREVENTION AND TREATMENT OF INFLAMMATORY AND / OR IMMUNIATED BONE LOSS
CY1105386T1 (en) BENZYLSULFONAMIDES AND SULFONYLBENZAMIDINES FOR USE AS ANTI-BULK AGENTS
UY26380A1 (en) FAB I INHIBITORS
DE50310516D1 (en) Fredericamycin DERIVATIVES
CY1113194T1 (en) COMPOSITION AND ANTI-ACTIVITY OF SUBSTITUTED AZAIDOLOLOXOXIC PRODUCERS OF SUBSTITUTE
CY1110385T1 (en) Use of IL-18 inhibitors for the treatment and / or prevention of atherosclerosis
EA200601553A1 (en) SUBSTITUTED BENZIMIDAZOLE-, BENZTRIASOLE- AND BENZIMIDAZOLONE-O-GLUCOSIDES
CY1113963T1 (en) PHARMACEUTICAL COMPOSITIONS WHICH INCLUDE ACTIVIA-COMPETITORS AND USE THESE IN PREVENTION OR MULTIPLE
EE200300440A (en) Combination of epothilone analogues and chemotherapeutic agents for the treatment of proliferative diseases
CY1107383T1 (en) SUSPENSIONS OF PHYSOLOGY SOLUTION A2
PA8567001A1 (en) ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS
CY1107985T1 (en) CCR1 competitors for the treatment of other degenerative inflammatory diseases
CY1119317T1 (en) COMPOSITION FOR LOCAL APPLICATION, USE OF THESE, APPLIANCES AND PART KITS
EA200401341A1 (en) APPLICATION OF OSTEOPROTEGERIN FOR THE TREATMENT AND / OR PREVENTION OF FIBROUS DISEASE
ATE400577T1 (en) ANNATED DIHYDROPYRANS
CY1113789T1 (en) COMBINATIONS FROM potassium channel actuators and sodium channel blockers or active substances affecting sodium channel transducers